Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Nanopore Technologies Raises £48.4M in Private Financing

NEW YORK – Oxford Nanopore Technologies said on Tuesday that it has raised £48.4 million ($59.7 million) in funding from new investors and existing shareholders in Europe, the Middle East and Africa (EMEA); the US; and Asia.

The new funding adds to £109.5 million — £29.3 million in new capital and £80.2 million from the sale of secondary shares — the company raised at the end of 2019. It brings its total funding raised to date to approximately £530 million.

Separately, Oxford Nanopore said last week that it is working on a SARS-CoV-2 detection test, called LamPore, that will run on its MinIon and GridIon nanopore sequencing platforms. The test, which the UK-based company is currently optimizing and validating with several collaborators, combines loop-mediated isothermal amplification (LAMP) and nanopore sequencing.

Oxford Nanopore also plans to seek regulatory approval for diagnostic use of the test, initially on the GridIon and later on the MinIon Mk1C. This is the first assay the firm is developing internally for diagnostic use.

A research-use-only version of LamPore is expected to become available in less than three weeks. This could be used for analyzing environmental samples for SARS-CoV-2, for example.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.